DK2717926T3 - COMPOSITIONS AND PROCEDURES FOR PREVENTION AND TREATMENT OF BIOFILM - Google Patents

COMPOSITIONS AND PROCEDURES FOR PREVENTION AND TREATMENT OF BIOFILM Download PDF

Info

Publication number
DK2717926T3
DK2717926T3 DK12800279.7T DK12800279T DK2717926T3 DK 2717926 T3 DK2717926 T3 DK 2717926T3 DK 12800279 T DK12800279 T DK 12800279T DK 2717926 T3 DK2717926 T3 DK 2717926T3
Authority
DK
Denmark
Prior art keywords
biofilm
trehalase
vol
trehalose
biofilms
Prior art date
Application number
DK12800279.7T
Other languages
Danish (da)
English (en)
Inventor
Dennis W Davis
Brad W Arenz
Thomas K Connellan
Svetlana A Ivanova
Original Assignee
Ziolase Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ziolase Llc filed Critical Ziolase Llc
Application granted granted Critical
Publication of DK2717926T3 publication Critical patent/DK2717926T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01028—Alpha,alpha-trehalase (3.2.1.28)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00—Metal working
    • Y10T29/49—Method of mechanical manufacture
    • Y10T29/49826—Assembling or joining

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Environmental Sciences (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Agronomy & Crop Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
DK12800279.7T 2011-06-13 2012-06-01 COMPOSITIONS AND PROCEDURES FOR PREVENTION AND TREATMENT OF BIOFILM DK2717926T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161520654P 2011-06-13 2011-06-13
US13/481,787 US20120315260A1 (en) 2011-06-13 2012-05-26 Compositions and Methods to Prevent and Treat Biofilms
PCT/US2012/040408 WO2012173796A2 (en) 2011-06-13 2012-06-01 Compositions and methods to prevent and treat biofilms

Publications (1)

Publication Number Publication Date
DK2717926T3 true DK2717926T3 (en) 2017-09-18

Family

ID=47293375

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12800279.7T DK2717926T3 (en) 2011-06-13 2012-06-01 COMPOSITIONS AND PROCEDURES FOR PREVENTION AND TREATMENT OF BIOFILM

Country Status (5)

Country Link
US (1) US20120315260A1 (cg-RX-API-DMAC7.html)
EP (1) EP2717926B1 (cg-RX-API-DMAC7.html)
JP (1) JP2015502179A (cg-RX-API-DMAC7.html)
DK (1) DK2717926T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012173796A2 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US10420822B2 (en) 2011-06-13 2019-09-24 Ziolase, Llc Compositions and methods to prevent and treat biofilms
US9549904B2 (en) 2012-06-06 2017-01-24 Thomas Bryan Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin
US9480669B2 (en) 2015-01-06 2016-11-01 The Regents Of The University Of California Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
DE102013201883B4 (de) * 2013-02-05 2025-11-20 Zyfoma Gmbh Verwendung einer wässrigen Lösung einer Säure als Behandlungsflüssigkeit zur Reinigung eines Implantat-Teils
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
EP2803372A1 (en) 2013-05-16 2014-11-19 Universiteit Twente Process for the preparation of an object supporting a lipid bilayer
US20180044628A1 (en) * 2015-03-13 2018-02-15 The Regents Of The University Of California Method for Biofilm Control and Treatment
CN112389060B (zh) * 2015-08-18 2023-04-18 威斯康星校友研究基金会 ClO2气体从医疗器械包装膜的释放
JP7002451B2 (ja) 2015-12-15 2022-01-20 ニオバスク ティアラ インコーポレイテッド 経中隔送達システム
CN108882981B (zh) 2016-01-29 2021-08-10 内奥瓦斯克迪亚拉公司 用于防止流出阻塞的假体瓣膜
AU2017264967B2 (en) * 2016-05-12 2024-07-25 The Trustees Of The University Of Pennsylvania Compositions and methods for inhibiting biofilm deposition and production
WO2018209345A1 (en) * 2017-05-12 2018-11-15 The Trustees Of The University Of Pennsylvania Compositions and methods for inhibiting biofilm deposition and production
AU2017361296B2 (en) 2016-11-21 2022-09-29 Neovasc Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
CA3055915A1 (en) * 2017-03-10 2018-09-13 Biohm Health Llc Compositions and methods for disrupting biofilms of pathogenic bacteria or fungi
WO2018226987A1 (en) 2017-06-07 2018-12-13 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same
EP3672530A4 (en) 2017-08-25 2021-04-14 Neovasc Tiara Inc. SEQUENTIALLY INSERTED TRANSCATHETER MITRAL VALVE PROSTHESIS
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
AU2019374743B2 (en) 2018-11-08 2022-03-03 Neovasc Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
US12226386B2 (en) 2018-12-03 2025-02-18 The Regents Of The University Of California Compositions and methods for treating biofilms
CN113747863B (zh) 2019-03-08 2024-11-08 内奥瓦斯克迪亚拉公司 可取回假体递送系统
AU2020256195B2 (en) 2019-04-01 2022-10-13 Neovasc Inc. Controllably deployable prosthetic valve
US11491006B2 (en) 2019-04-10 2022-11-08 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
CA3282225A1 (en) 2019-05-20 2026-03-02 Neovasc Tiara Inc. Introducer with hemostasis mechanism
JP7520897B2 (ja) 2019-06-20 2024-07-23 ニオバスク ティアラ インコーポレイテッド 薄型人工補綴僧帽弁
CN110538314B (zh) * 2019-09-28 2024-09-13 上海泌码生命科学有限公司 用于杀灭已形成生物膜的铜绿假单胞菌的抗菌肽组合物
CN113769148B (zh) * 2021-09-27 2023-03-21 中国科学院微生物研究所 PslG蛋白在隐形眼镜护理液中的应用
US12109176B1 (en) 2023-04-20 2024-10-08 Thomas Bryan Effect of glycerol on biofilm forming bacteria and fungi that changes the microbes sensitivity to pro and anti-biofilm non-toxic, non-bonded plasma amino acids and amino acid derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0751063A (ja) * 1993-06-11 1995-02-28 Kirin Brewery Co Ltd 逆反応性を有するトレハラーゼ、およびα,α−トレハロースの製造方法
JP3659985B2 (ja) * 1993-12-28 2005-06-15 三栄源エフ・エフ・アイ株式会社 トレハラーゼ及び該酵素を用いた糖類の製法
EP0820516B1 (en) * 1995-04-07 2002-03-06 BetzDearborn, Inc. Exopolysaccharide degrading enzyme and use of the same
JP2000508175A (ja) * 1996-04-10 2000-07-04 メルク エンド カンパニー インコーポレーテッド 組み換え酵母用培地を改良する方法
IN1997CH00924A (en) * 1996-05-03 2005-03-04 Syngenta Mogen Bv Regulating metabolism by modifying the level of trehalose-6-phosphate
US6759040B1 (en) * 1997-09-12 2004-07-06 University Of Maryland, College Park Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures
US20020022005A1 (en) * 1997-10-16 2002-02-21 Budny John A. Compositions for treating cystic fibrosis
US5871714A (en) * 1997-10-16 1999-02-16 Pharmacal Biotechnologies, Inc. Compositions for controlling bacterial colonization
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
EP1081232A1 (en) * 1999-08-30 2001-03-07 K.U. Leuven Research & Development Novel target for antifungals
JP3959439B2 (ja) * 2001-08-21 2007-08-15 学校法人 東洋大学 耐熱性トレハラーゼと、その製造法
EP1796687A2 (en) * 2004-09-14 2007-06-20 Elixir Pharmaceuticals, Inc. Combination therapy for controlled carbohydrate digestion
US20080139450A1 (en) * 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
EP1872791A1 (en) * 2006-06-30 2008-01-02 Institut Pasteur Use of bacterial polysaccharides for biofilm inhibition
NO2254591T3 (cg-RX-API-DMAC7.html) * 2008-02-08 2017-12-23
US9931381B2 (en) * 2009-11-23 2018-04-03 Prothera, Inc. Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

Also Published As

Publication number Publication date
WO2012173796A3 (en) 2013-05-02
WO2012173796A2 (en) 2012-12-20
EP2717926A4 (en) 2014-12-31
JP2015502179A (ja) 2015-01-22
EP2717926A2 (en) 2014-04-16
US20120315260A1 (en) 2012-12-13
EP2717926B1 (en) 2017-05-24

Similar Documents

Publication Publication Date Title
EP2717926B1 (en) Compositions and methods to prevent and treat biofilms
US10758596B2 (en) Compositions and methods to prevent and treat biofilms
CA3088187A1 (en) Compositions and methods to prevent and treat biofilms
US20200078448A1 (en) Compositions and methods to prevent and treat biofilms
JP6869637B2 (ja) 抗菌性組成物
Cos et al. Biofilms: an extra hurdle for effective antimicrobial therapy
Coughlan et al. New weapons to fight old enemies: novel strategies for the (bio) control of bacterial biofilms in the food industry
Vani et al. A narrative review on bacterial biofilm: Its formation, clinical aspects and inhibition strategies
De Carvalho Biofilms: recent developments on an old battle
JP6244291B2 (ja) 胃腸のバイオフィルムの抑制および治療
US20110274730A1 (en) Biosurfactant composition produced by a new bacillus licheniforms strain, uses and products thereof
SG184836A1 (en) Method of reducing biofilms
US9357792B2 (en) Fermented cereal product obtained by fermentation of rye bran with a Lactobacillus curvatus strain
Khan et al. Contribution of chitooligosaccharides to biofilm formation, antibiotics resistance and disinfectants tolerance of Listeria monocytogenes
US20260137086A1 (en) Methods to reduce contamination, biofilm and fouling from water systems, surfaces, and products
US9480729B2 (en) Enzymes for inhibiting growth of biofilms and degrading same
CN101528686A (zh) 酰胺化合物或其盐,以及各自使用该酰胺化合物或其盐的生物膜形成抑制剂、生物膜去除剂和杀菌剂
Percival et al. An introduction to the world of microbiology and biofilmology
Liaqat et al. Biofilm, dental unit water line and its control
Bekele et al. Bacterial biofilms; links to pathogenesis and resistance mechanism
Atanasković et al. Enzyme-based strategies for inhibiting medically relevant biofilms: applications in healthcare and food safety
Garner The effects of quorum sensing molecules on Streptococcus mutans biofilm
Kao et al. Biofilm disease and otitis
THALLINGER Functionalization of catheters with antimicrobial enzymes
Sampathkumar et al. 84 Food Processing Biofilms and Antimicrobial Agents